Position in INSM
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$46,299,216
-$13,003,173 QoQ
Shares Held
283,141
-16.9% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $466,757,935 across 164 Biotechnology names. INSM ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
373,532 | $166,796,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
152,397 | $117,748,018 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,013 | $57,575,681 | |
| 4 | INSM |
INSMED Inc
This page
|
283,141 | $46,299,216 | |
| 5 | INCY |
Incyte Corp
|
49,678 | $4,675,693 | |
| 6 | MRNA |
Moderna, Inc.
|
71,342 | $3,624,173 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
31,677 | $2,352,334 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
31,498 | $1,974,924 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,299,216 | 283,141 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $59,302,389 | 340,740 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,084,395 | 7,530 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $684,452 | 6,801 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,470,355 | 45,489 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,934,658 | 56,991 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,909,050 | 39,850 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,019,380 | 30,140 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $956,088 | 35,241 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $992,392 | 32,023 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $669,756 | 26,525 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $548,030 | 25,973 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $432,507 | 25,367 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $571,408 | 28,599 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $500,568 | 23,239 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $447,742 | 22,705 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $809,645 | 34,453 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,156,828 | 42,468 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,083,809 | 39,354 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,350,398 | 47,449 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,406,916 | 41,307 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,269,946 | 38,148 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $924,410 | 28,762 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $823,583 | 29,905 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $280,589 | 17,504 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||